WELLINGTON, June 21 (Reuters) - New Zealand's drug treatments regulator Medsafe has provisionally authorized the use of the Pfizer/BioNTech coronavirus vaccine for 12- to fifteen-yr-olds, Prime Minister Jacinda Ardern announced on Monday (Jun 21).
“After careful attention of the maximum up to date medical and clinical information to be had, Medsafe has announced provisional approval for our young human beings to accept the Pfizer vaccine,” Ardern said in a assertion.
There are round 265,000 kids within the 12 to 15 age bracket in New Zealand, she stated.
About 1 million doses of the Pfizer vaccine have to this point been administered in New Zealand, a kingdom of five million humans.
The united states's clinical government are yet to approve the usage of some other vaccine, inclusive of AstraZeneca.
Pressure has been mounting at the authorities to hurry up vaccinations and reopen its borders. Ardern has said having greater people vaccinated offers the state more alternatives at the border.
No comments:
Post a Comment